Co-Diagnostics Joins WHO Consultation on Global Diagnostics
Salt Lake City, Utah, U.S., September 17, 2026 Co-Diagnostics, Inc., a molecular diagnostics company developing technologies for infectious disease...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Salt Lake City, Utah, U.S., September 17, 2026 Co-Diagnostics, Inc., a molecular diagnostics company developing technologies for infectious disease...
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...
SALT LAKE CITY, July 22, 2026 Co-Diagnostics, Inc. has announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd.,...
SALT LAKE CITY, Utah, July 21, 2026 Seek Labs announced the publication of peer-reviewed research in Nature Communications validating...
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
SALT LAKE CITY, Utah, July 1, 2026 Co-Diagnostics, Inc. has reached a significant regulatory milestone by completing the clinical...
BATH, England — November 26, 2025. Innotive Diagnostics (InnotiveDx) has been awarded a £1 million grant from PACE, one...
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
